世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033371

世界の中枢神経系(CNS)バイオマーカー市場調査レポート2021-2032

Fatpos Global

Global Central Nervous System (CNS) Biomarkers Market Research Report 2021-2032

発刊日 2022/10

言語英語

体裁Word-PDF/171ページ

ライセンス/価格171ページ

0000033371

Single
Global Site License

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。Word-PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界の中枢神経系(CNS)バイオマーカー市場レポートは、世界市場の包括的な見通しを示すために、市場規模、シェア、売上、予測動向、供給、生産、需要、業界、CAGR などのいくつかの決定的要因を詳細に理解することを重視しています。さらに、このレポートは、「中枢神経系(CNS)バイオマーカー」で主要企業が採用している市場の成長と拡大戦略を妨げている課題についても言及しています。

このレポートで紹介されている主要企業:
Thermo Fisher Scientific
Merck & Co.
AbaStarMDx Inc.
Abiant, Inc.
Avacta Group plc
Diagenetic Asa
Banyan Biomarkers
Avid Radiopharmaceuticals Inc.
Acumen Pharmaceuticals Inc.
Siemens AG
Novartis
G-Biosciences
Merck KGaA
Bio-Rad Laboratories, Inc.
Biomeriux (Banyan Biomarkers Inc.)

レポート詳細

目次

Contents

1. Executive Summary

2. Global Central Nervous System (CNS) Biomarkers Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. Average Pricing Analysis

5. Macro-Economic Indicators

6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix

8. Recent Development, Policies & Regulatory Landscape

9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. Global Central Nervous System (CNS) Biomarkers Market Analysis
10.1. Porter Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological

11. Global Central Nervous System (CNS) Biomarkers Market
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F

12. Global Central Nervous System (CNS) Biomarkers Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. the Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Solutions & Services: Market Share (2020-2031F)
12.2.1. Engagement & Performance Services, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Strategic Services, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Consulting & Professional Services, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Marketing, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Sales, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Product Development, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.4. Human Resource, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.5. Other, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By End-User: Market Share (2020-2031F)
12.4.1. Banking, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Retail, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Government, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Education, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.5. IT & Telecom, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.6. Healthcare, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.7. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F

13. Company Profile
Thermo Fisher Scientific
Merck & Co.
AbaStarMDx Inc.
Abiant, Inc.
Avacta Group plc
Diagenetic Asa
Banyan Biomarkers
Avid Radiopharmaceuticals Inc.
Acumen Pharmaceuticals Inc.
Siemens AG
Novartis
G-Biosciences
Merck KGaA
Bio-Rad Laboratories, Inc.
Biomeriux (Banyan Biomarkers Inc.)

Consultant Recommendation
The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

この商品のレポートナンバー

0000033371

TOP